Milestone Scientific (MLSS) Net Income towards Common Stockholders (2010 - 2026)

Milestone Scientific has disclosed Net Income towards Common Stockholders across 17 years of filings, most recently posting -$839853.0 for Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at -$839853.0, up 57.89% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.6 million (up 13.29% YoY), and the FY2025 annual result was -$5.7 million, down 21.4% from the prior year.
• Net Income towards Common Stockholders came in at -$839853.0 for Q1 2026 at Milestone Scientific, up from -$1.1 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $223638.0 in Q2 2024 to a low of -$2.9 million in Q2 2022.
• The 5-year median for Net Income towards Common Stockholders is -$1.5 million (2025), against an average of -$1.6 million.
• Across the five-year window, Net Income towards Common Stockholders soared 110.03% in 2024 and slumped 763.17% in 2025, its largest moves.
• Milestone Scientific's Net Income towards Common Stockholders stood at -$2.0 million in 2022, then climbed by 1.52% to -$2.0 million in 2023, then decreased by 4.03% to -$2.0 million in 2024, then soared by 46.42% to -$1.1 million in 2025, then increased by 22.99% to -$839853.0 in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$839853.0 (Q1 2026), -$1.1 million (Q4 2025), and -$1.2 million (Q3 2025), per Business Quant data.